BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 6:27:00 PM | Browse: 1058 | Download: 967
Publication Name World Journal of Stem Cells
Manuscript ID 6878
Country Brazil
Received
2013-10-29 18:16
Peer-Review Started
2013-10-30 16:20
To Make the First Decision
2013-11-19 13:00
Return for Revision
2013-11-20 09:04
Revised
2013-12-14 01:29
Second Decision
2014-03-12 18:35
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-03-12 18:42
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-04-02 14:30
Typeset the Manuscript
2014-04-19 17:32
Publish the Manuscript Online
2014-04-28 14:14
ISSN 1948-0210 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Neurosciences
Manuscript Type Topic Highlights
Article Title Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials
Manuscript Source Invited Manuscript
All Author List Ana Maria Blanco Martinez, Camila de Oliveira Goulart, Bruna dos Santos Ramalho, Júlia Teixeira Oliveira and Fernanda Martins Almeida
Funding Agency and Grant Number
Corresponding Author Ana Maria Blanco Martinez, MD, PhD, Laboratory of Neurodegeneration and Repair, Institute of Biomedical Sciences, Health Science Center, bloco F - sala 12, 21941-902, Rio de Janeiro, Brazil. martinez@histo.ufrj.br
Key Words Neurotrauma; Stem cell therapy; Mesenchymal stem cells; Pre-clinical studies; Clinical trials
Core Tip Basic and pre-clinical studies have highlighted the positive effects of mesenchymal stem cell (MSC) treatment after spinal cord injury (SCI) and nerve trauma. There are many pre-clinical studies on MSC treatment for SCI and nerve injuries. However, the same is not true for clinical trials, particularly those concerned with nerve trauma. As for clinical trials for SCI, the results obtained so far are not as beneficial as those described in experimental studies. For these reasons basic and pre-clinical studies dealing with MSC therapy should emphasize the standardization of protocols that could be translated to the clinical set with consistent and positive outcomes.
Publish Date 2014-04-28 14:14
Citation Martinez AMB, Goulart CO, Ramalho BS, Oliveira JT, Almeida FM. Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials. World J Stem Cells 2014; 6(2): 179-194
URL http://www.wjgnet.com/1948-0210/full/v6/i2/179.htm
DOI http://dx.doi.org/10.4252/wjsc.v6.i2.179
Full Article (PDF) WJSC-6-179.pdf
Full Article (Word) WJSC-6-179.doc
Manuscript File 6878-Review.doc
Answering Reviewers 6878-Answering reviewers.pdf
Copyright License Agreement 6878-Copyright assignment.pdf
Peer-review Report 6878-Peer review(s).pdf
Scientific Editor Work List 6878-Scientific editor work list.doc